23 C
New York
Sunday, June 14, 2026

Tag: rates

newssourceFORcompanyinformationcontent1marketreleases

FLAGSTAR BANK, N.A. ANNOUNCES PRELIMINARY RESULTS OF 2026 ANNUAL SHAREHOLDERS’ MEETING

HICKSVILLE, N.Y., June 9, 2026 /PRNewswire/ -- Flagstar Bank, N.A. (NYSE: FLG) (the "Bank") announced today that, based on preliminary voting results from the...

AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS

PRESS RELEASE

Liquisite and eMazzanti Technologies Deliver Enterprise-Grade Digital Marketing, With the Brand Growth Backbone Your Business Demands

A flexible, ROI-driven platform combining award-winning web design, deep digital marketing expertise, and decades of cybersecurity leadershipHOBOKEN, N.J., June 9, 2026 /PRNewswire/ -- In...

Ubisoft launches a new employee shareholding operation

UBISOFT ENTERTAINMENT S.A.

Ally Medical ER Is Coming to Magnolia

Ally Medical Emergency Room is opening in Magnolia, TX near FM 1488 in 2027 — 24/7 care, board-certified physicians, no wait times for Montgomery County.

1Q 2026 Campus Switch Shipments Grow Double Digits as Prices Rise Due to Component Shortages, According to Dell’Oro Group

AI Security Threat Reinforces Cisco's Refresh StrategyREDWOOD CITY, Calif., June 9, 2026 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the trusted...

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

MBRYONICS, ANNOUNCES OPTICAL COMMUNICATIONS BREAKTHROUGH FOR SPACE

MBRYONICS Unveils STARLIGHT, The World's First 25G/100G/400G/800G Bi-Directional Coherent Optical Transceiver for Ultra High Speed Space LinksGALWAY,  Ireland, June 9, 2026 /PRNewswire/ -- MBRYONICS,...

P2 Gold Gabbs Project Update: Feasibility Study on Track

VANCOUVER, BC, June 9, 2026 /CNW/ - P2 Gold Inc. ("P2" or the "Company") (TSXV: PGLD) (OTCQB: PGLDF) provides an update on the activities underway...

EHang Reports First Quarter 2026 Unaudited Financial Results

GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

TAIPEI, June 9, 2026 /PRNewswire/ -- ASE Technology Holding Co., Ltd. (NYSE: ASX, TWSE: 3711, "ASEH" or the "Company"), announces its unaudited consolidated net...

Progress on share buyback programme

Progress on share buyback programme

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

Defiance Launches MUZ: The First 2X Short ETF for Micron Technology, Inc.

IDEAYA Announces Pricing of $300 Million Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., June 8, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public offering of common...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRates

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers